Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.
about
Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalisCurrent progress with Moraxella catarrhalis antigens as vaccine candidatesCharacterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly.Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.Intranasal immunization of the combined lipooligosaccharide conjugates protects mice from the challenges with three serotypes of Moraxella catarrhalis.Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.Vaccines based on the cell surface carbohydrates of pathogenic bacteria.Vaccine targets against Moraxella catarrhalis.Prospects for a vaccine against otitis media.Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination.Mouse models for the study of mucosal vaccination against otitis media.Mucosal vaccination against bacterial respiratory infections.Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.Moraxella catarrhalis: from interactions with the host immune system to vaccine development.A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: an update on current progress and challenges.Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera.Mapping protective regions on a three-dimensional model of the Moraxella catarrhalis vaccine antigen, Oligopeptide Permease A.
P2860
Q24684942-242A6831-FCC2-4848-A867-4E2F6AC4D847Q28304447-90ED4701-ECE4-434B-A930-2CC26E0CD802Q33755304-B1D25C20-A70C-4381-9BBF-9885BD55236EQ33768943-61D65C07-3C50-4263-967D-57F41716A6F2Q34117703-91FDA03F-BDEB-4DF3-B818-CE446227BB7DQ35029651-F2888A4F-32BE-4474-BB02-480CE320C143Q36128243-30A5F58E-8FA2-448B-8FBE-0D5053FA8FDDQ36483998-54167244-2427-405E-9D91-A5C62EA4EAB1Q36600356-1B460C62-FC87-47EF-BCA2-10543AC4D131Q36845123-0475D23E-0D64-4EEC-B9D9-4D6784E6CEF3Q37093093-AC41FD25-7ADB-4CA0-BE27-437B5F875BACQ37290114-C7F634F3-9452-4AE5-8F0D-1A25D8384939Q37355837-4415FBC9-92B7-417F-8BA6-D9A1F792B5C3Q37441243-B47A9A04-C421-4CE0-BB92-990126B4BB8CQ38041190-031BA2CF-6BF4-4902-A1C6-7885F54B2415Q40074756-B5EF32A6-55CB-4CF2-B8DE-77A23DCCAB12Q42601451-7B42044B-D0BB-4D6C-A64C-6A36536C0734Q47332587-3E799092-86D3-4528-AEFB-3909D624E3BA
P2860
Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Specific immune responses and ...... osaccharide conjugate vaccine.
@ast
Specific immune responses and ...... osaccharide conjugate vaccine.
@en
Specific immune responses and ...... osaccharide conjugate vaccine.
@nl
type
label
Specific immune responses and ...... osaccharide conjugate vaccine.
@ast
Specific immune responses and ...... osaccharide conjugate vaccine.
@en
Specific immune responses and ...... osaccharide conjugate vaccine.
@nl
prefLabel
Specific immune responses and ...... osaccharide conjugate vaccine.
@ast
Specific immune responses and ...... osaccharide conjugate vaccine.
@en
Specific immune responses and ...... osaccharide conjugate vaccine.
@nl
P2093
P2860
P1476
Specific immune responses and ...... osaccharide conjugate vaccine.
@en
P2093
Takashi Hirano
Xin-Xing Gu
Xinan Jiao
Yingchun Hou
P2860
P304
P356
10.1128/IAI.70.11.5982-5989.2002
P407
P577
2002-11-01T00:00:00Z